Published On: Thu, Sep 14th, 2017

AAC Holdings, Inc. (NYSE:AAC) – Brokers Update Their Views


A number of investment brokers have recently updated their price targets on shares of AAC Holdings, Inc. (NYSE:AAC).

Most recent broker ratings

08/10/2017 – Cantor Fitzgerald began new coverage on AAC Holdings, Inc. giving the company a “overweight” rating. They now have a USD 11 price target on the stock.

05/30/2017 – AAC Holdings, Inc. had its “neutral” rating reiterated by analysts at Mizuho. They now have a USD 6 price target on the stock.

11/03/2016 – AAC Holdings, Inc. had its “mkt perform” rating reiterated by analysts at Raymond James.

11/19/2015 – AAC Holdings, Inc. had its “outperform” rating reiterated by analysts at William Blair.

05/01/2015 – AAC Holdings, Inc. was downgraded to “hold” by analysts at Zacks.

10/27/2014 – Avondale Partners began new coverage on AAC Holdings, Inc. giving the company a “outperform” rating.

The share price of AAC Holdings, Inc. (NYSE:AAC) was down -7.39% during the last day of trading, with a day high of 12.57. 156226 shares were traded during the last session.

The stock’s 50 day moving average is 8.63 and its 200 day moving average is 7.72. The stock’s market capitalization is 280.30M. AAC Holdings, Inc. has a 52-week low of 5.99 and a 52-week high of 19.98.

AAC Holdings, Inc. is a provider of inpatient and outpatient substance abuse treatment services for individuals with drug and alcohol addiction. The Company performs drug testing and diagnostics laboratory services and provides physician services to its clients. As of June 30, 2016, the Company operated 12 residential substance abuse treatment facilities located throughout the United States, focused on delivering clinical care and treatment solutions across 1,139 beds, which includes 636 licensed detoxification beds, and 18 standalone outpatient centers. In addition, the Company focuses on expanding The Oxford Centre facility. As of June 30, 2016, the Company’s capacity at its Forterus treatment facility was 14 beds. The Company is engaged in deploying research-based treatment programs with structured curricula for detoxification, residential treatment, partial hospitalization and intensive outpatient care. The Company is also an Internet marketer in the addiction treatment industry.